SENORESNSEOffline
SENORES PHARMACEUTIC · INE0RB801010 · Small Cap · #847- Prev close
- 1,137.00
- Open
- —
- High
- —
- Low
- —
- Volume
- —
- Mkt cap (6-mo avg)
- ₹4,192 cr
Loading minute bars…
NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.
SENORES is 23% below its 52-week high, above its 200-day average — a Small Cap company, #847 by market cap.NSE prices to 05 Nov 2026 · a description of the data, not advice
Overview
What the data says, line by line
A description, never a buy or sell word · tap a line for its detail
How big is it?
six-month average market cap
Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.
Did buyers take delivery?
latest session · 2026-11-05
Price & trend
Returns
to 05 Nov 2026
| Period | Stock | vs Nifty 500 | vs its industry |
|---|---|---|---|
| 1 week | −2.6% | −8.0 pts | — |
| 1 month | −14.5% | −18.2 pts | — |
| 3 months | −10.2% | −8.3 pts | — |
| 6 months | +29.7% | +29.2 pts | — |
| 1 year | +53.2% | +57.3 pts | — |
Points = the stock’s return minus the benchmark’s. Prices adjusted for splits and bonuses.
Averages & movement
Ownership
Who owns the company
% of all shares, by quarter
| Group | Dec 25 | Mar 26 | Jun 26 | Sep 26 |
|---|---|---|---|---|
| Promoters | 45.8% | 45.8% | 45.8% | 45.8% |
| FPI | 3.4% | 3.6% +0.3 | 6.6% +3.0 | 6.0% −0.6 |
| Mutual funds | 4.9% | 5.1% +0.2 | 6.6% +1.5 | 7.4% +0.8 |
| Other DII | 4.4% | 4.6% +0.1 | 3.2% −1.3 | 3.5% +0.3 |
| Individuals | 32.0% | 31.6% −0.3 | 29.2% −2.4 | 29.4% +0.1 |
| Others | 9.6% | 9.3% −0.3 | 8.6% −0.7 | 7.9% −0.6 |
From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.
Promoter pledge
Sep 26
Holders
Sep 26
Indian passive funds’ stake
2026-06-30
1,008 shares held by Indian passive mutual-fund schemes. A floor, not the total — foreign ETFs, insurance and EPFO are not counted.
Which funds bought and sold
mutual funds · quarter ended 2026-06-30
| Fund | Shares | Change | Did |
|---|---|---|---|
| HSBC Multi Cap Fund-Reg(G)Active | +1,60,503 | +86.6% | bought |
| HSBC Small Cap Fund-Reg(G)Active | +2,09,794 | +52.6% | bought |
| Mahindra Manulife Large & Mid Cap Fund-Reg(G)Active | −1,06,337 | −19.7% | sold |
| Mahindra Manulife Balanced Advantage Fund-Reg(G)Active | −17,000 | −15.9% | sold |
Ranked by how much each fund changed its own position, not by size of trade. Every fund here still holds the company — one that sold out entirely leaves no record to find.
Mutual-fund schemes, month by month
fund houses’ own monthly portfolios
| Month | Schemes | Bought new | Added | Cut | Sold out | Shares held | Value |
|---|---|---|---|---|---|---|---|
| Sep 26 | 22 | 6 | 4 | 1 | 0 | +12.0% | ₹400 cr |
| Aug 26 | 16 | 1 | 6 | 4 | 1 | −4.9% | ₹369 cr |
| Jul 26 | 16 | 7 | 4 | 0 | 4 | +8.5% | ₹354 cr |
| Jun 26 | 13 | 5 | 3 | 2 | 3 | +32.5% | ₹332 cr |
| May 26 | 11 | 4 | 2 | 2 | 1 | +23.2% | ₹211 cr |
| Apr 26 | 8 | 3 | 2 | 2 | 0 | −9.4% | ₹137 cr |
Each month against the one before, counting only the fund houses that reported both (45 houses in Sep 26); a split or bonus is divided out first. “Partial” = fewer than five houses reported yet.
Fund ownership is a quarterly disclosure and counts Indian passive schemes only.
Results
Results
Events & filings
Insider trades
SEBI PIT disclosures filed with NSE
| 10 Aug 2026 | ASHOKKUMAR VIJAYSINH BAROT | Promoter | Buy | 30,000 | ₹0 | 0.08% | Off Market |
| 10 Aug 2026 | DHANANJAY ASHOKKUMAR BAROT | Promoter Group | Sell | 30,000 | ₹0 | 0.01% | Off Market |
| 10 Aug 2026 | DHANANJAY ASHOKKUMAR BAROT | Promoter Group | Sell | 30,000 | ₹0 | 0.01% | Off Market |
| 10 Aug 2026 | ASHOKKUMAR VIJAYSINH BAROT | Promoter | Buy | 30,000 | ₹0 | 0.08% | Off Market |
| 10 Aug 2026 | DHANANJAY ASHOKKUMAR BAROT | Promoter Group | Sell | 30,000 | ₹0 | 0.01% | Off Market |
| 10 Aug 2026 | ASHOKKUMAR VIJAYSINH BAROT | Promoter | Buy | 30,000 | ₹0 | 0.08% | Off Market |
| 28 Mar 2026 | Renosen Pharmaceuticals Private Limited | Promoter Group | Buy | 7,39,000 | ₹60.01 cr | 63.16% | Others |
| 28 Mar 2026 | Sangeeta Mukur Barot | Promoter Group | Buy | 61,500 | ₹4.99 cr | 5.26% | Others |
| 28 Mar 2026 | Ashokbhai Vijaysinh Barot | Promoters | Buy | 1,23,000 | ₹9.99 cr | 10.51% | Others |
| 28 Mar 2026 | Swapnil Jatin Shah | Promoters | Buy | 1,97,000 | ₹16 cr | 16.84% | Others |
| 28 Mar 2026 | Viraj Ashokkumar Barot | Promoter Group | Buy | 49,500 | ₹4.02 cr | 4.23% | Others |
| 13 Feb 2026 | Renosen Pharmaceuticals Private Limited | Promoter Group | Pledge Revoke | 4,00,000 | ₹31.34 cr | 5.90% | Revokation of Pledge |
| 13 Feb 2026 | Espee Therapeutics LLP | Promoter Group | Pledge | 4,00,000 | ₹31.34 cr | 1.07% | Pledge Creation |
| 31 Dec 2025 | Renosen Pharmaceuticals Private Limited | Promoter Group | Buy | 6,000 | ₹0.49 cr | 5.90% | Market Purchase |
| 17 Dec 2025 | Renosen Pharmaceuticals Private Limited | Promoter Group | Buy | 4,000 | ₹0.32 cr | 5.89% | Market Purchase |
Sums count buys and sells of equity (market and off-market); pledges are listed but not summed. From NSE’s filings: the archive to 2 May 2026, its XBRL filings since (NSE circular NSE/CML/2026/12). A filing describes what was done, not why.
Disclosures & deals
last six months · NSE filings
- Board outcome29 Oct 2026
- Board outcome13 Oct 2026
- Board outcome27 Aug 2026
- Scheme / acquisition27 Aug 2026
- Board outcome27 Jul 2026
- Board outcome27 Jul 2026
Latest shown; 7 in six months on all disclosures.
SENORES: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.
Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.